World monkeys OP166 100 µg €294
Anti-CD47 Mouse mAb (2D�) APOP, FC, IF, IP human OP167 100 µg €294
Anti-CD49d Mouse mAb (BU49) CIA, FC, FS, IP human 217600 100 µg €209
Anti-CD49d Mouse mAb (BU49
Ch. Boone, Systematic genetic
analysis with ordered arrays of yeast deletion mutants. Science, 294, pp 2364 –
2368, 2001
R. Breitling, S. Klingner, N. Callewaert, R. Pietrucha, A. Geyer, G. Ehrlich
368-380 of human ATM . Recognizes the ~350 kDa ATM protein in Daudi and HeLa cells . IP
200 mg €294
Anti-ATM (Ab-3) (819-844) Rabbit pAb PC116 Liquid, purified . Immunogen used was a synthetic peptide
responsible for the migration
of Thy-1+DEC to the epidermis.
J.Invest.Dermatol. 1994; 103: 290-294.
116. Trumble TE, Parvin D: Cell viability and
migration in nerve isografts and allografts.
Quant. Biol. 70, 205 .
Dean, M ., et al . 2005 . Nat. Rev. Cancer 5, 275 .
Weissman, I . 2005 . JAMA 294, 1359 .
Christopherson, K .W . et al . 2004 . Science 305, 1000 .
Ding, S .
vascular endothelial cells in normal tissues and benign and malignant proliferations .
FC, PS
100 mg €294
Anti-Pax3 Rabbit pAb CA1010 Liquid, polyclonal IgG, undiluted serum . Immunogen used was a recombinant
20648 Snta1 P NP_033254.2 n/d n/d y
742 Tumor Necrosis Factor-a T2824 21926 Tnf P NP_038721.1 n/d y y
294 GAP1IP4BP G6666 22821 RASA3 M NP_031394.2 y n/d n/d
413 LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/
20648 Snta1 P NP_033254.2 n/d n/d y
742 Tumor Necrosis Factor-a T2824 21926 Tnf P NP_038721.1 n/d y y
294 GAP1IP4BP G6666 22821 RASA3 M NP_031394.2 y n/d n/d
413 LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/
20648 Snta1 P NP_033254.2 n/d n/d y
742 Tumor Necrosis Factor-a T2824 21926 Tnf P NP_038721.1 n/d y y
294 GAP1IP4BP G6666 22821 RASA3 M NP_031394.2 y n/d n/d
413 LDS1 L4793 23028 AOF2 P NP_001009999.1 y n/
108963 209
Refractive index standard traceable to SRM from NIST and PTB 0° Brix Certipur® 500400 209
Refractive index standard traceable to SRM from NIST and PTB 5° Brix Certipur® 500405 209
Refractive
Science 294,
89–92.
4. Service, R. F. (2001) Science 292,
187–188.
5. Brush, M. (2002) The Scientist 16,
38–41.
6. Knaust, R. K. C. and Nordlund, P.
(2001) Anal. Biochem. 297, 79–85.
7. Braun
Recombinant Proteins in E. coli is Favored by Lower Growth
Temperature
Bio/Technology 6, 291 - 294 (1988)
(39) Liepnicks, J.J. and Light, A.
The Preparation and Properties of Enterokinase
J.
Recombinant Proteins in E. coli is Favored by Lower Growth
Temperature
Bio/Technology 6, 291 - 294 (1988)
(39) Liepnicks, J.J. and Light, A.
The Preparation and Properties of Enterokinase
J.
Recombinant Proteins in E. coli is Favored by Lower Growth
Temperature
Bio/Technology 6, 291 - 294 (1988)
(39) Liepnicks, J.J. and Light, A.
The Preparation and Properties of Enterokinase
J.
n/d
205 Cytokeratin peptide 7 C6417 M y n/d n/d
206 Cytokeratin 8.12 C7034 M y n/d n/d
207 Cytokeratin 8.13 C6909 M y n/d n/d
208 Cytokeratin peptide 13 C0791 M y n/d n/d
209 Cytokeratin Peptide 17 C9179
13703–13708.
2. Ritz, D., Lim, J., Reynolds, C. M.,
Poole, L. B., and Beckwith, J. (2001)
Science 294, 158–160.
T7Select host strain genotypes and descriptions
Strain*
Origami B 5615 F– ompT hsdSB